El-Hattab A W et al. Molecular and clinical spectra of FBXL4 deficiency. Hum Mutat. 2017;38(12):1649-1659. PMID: 28940506.
Antoun G et al.Detailed Biochemical and Bioenergetic Characterization of FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion.JIMD Rep. 2016;27:1-9. PMID: 26404457.
Bonnen P E et al.Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance.Am J Hum Genet. 2013;93(3):471-81. PMID: 23993193.
Dai H et al. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome.Clin Genet. 2017;91(4):634-639. PMID: 27743463.
Gai X et al.Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am J Hum Genet. 2013;93(3):482-95. PMID: 23993194.
Huemer M et al.Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations. J Inherit Metab Dis. 2015;38(5):905-14. PMID: 25868664.
Morton S U et al.Hyperammonemia as a Presenting Feature in Two Siblings with FBXL4 Variants. JIMD Rep. 2017;35:7-15. PMID: 27858371.
Pronicka E et al.New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre.J Transl Med. 2016;14(1):174. PMID: 27290639.
Van Rij M C et al.Polyhydramnios and cerebellar atrophy: a prenatal presentation of mitochondrial encephalomyopathy caused by mutations in the FBXL4 gene.Clin Case Rep. 2016;4(4):425-428. PMID: 27099744.